ZEISS (Germany) and BOSELLO HIGH TECHNOLOGY (BOSELLO) (Italy) have announced that the ZEISS Group will acquire a majority stake in the provider of industrial X-ray solutions.For ZEISS, BOSELLO’s tailor-made solutions are a further step in the process of evolving into a one-stop provider of ... more
New Chairman of Supervisory Board at Carl Zeiss AGDr. Dieter Kurz elected with immediate effect
The Carl Zeiss AG Supervisory Board has elected Dr. Dieter Kurz as the new Chairman of the Supervisory Board, effective immediately.
Born in 1948, Dr. Dieter Kurz studied physics at the University of Tübingen, from which he also received his doctorate. He joined Carl Zeiss in 1979. After holding several responsible positions in research and development, marketing and sales, including a two-year stay in North America, he headed the Semiconductor Optics division and Semiconductor Manufacturing Technology busi- ness group. In 1999 he became a Member of the Executive Board and was appointed President and CEO in 2001. After the two Foundation enterprises had been transformed into stock corporations (AG) and the appropriate amendments to the Foundation's constitution had come into effect, he was President and CEO of Carl Zeiss AG from 2004 to the end of 2010.
Kurz is also Chairman of the Shareholder Council of the Carl Zeiss Foundation, Heidenheim and Jena, which is the sole shareholder of Carl Zeiss AG. He succeeds Dr. Theo Spettmann who held these offices from February 2010 and who stepped down for health reasons at the beginning of March 2012.
- Carl Zeiss
In the past 2016/17 fiscal year (ended 30 September 2017), ZEISS increased both its revenue and earnings to a record level: revenue rose by 10 percent to EUR 5.348 billion (prior year: EUR 4.881 billion). At EUR 770 million, earnings before interest and tax (EBIT) were significantly above t ... more
The Supervisory Board of Carl Zeiss AG has decided to expand the Executive Board of the ZEISS Group, which currently has four members. This is in line with the implementation of the ZEISS portfolio strategy and anchors the business responsibility in the Executive Board. Effective 1 January ... more
- From exposomics to phytotoxins: Safe foodstuffs in the focus of analytica 2018
- 22 new genetic risk factors for stroke identified
- Brown adipose tissue made transparent
- Young start-up team develops new reference materials for direct microanalysis of solids
- Trends in Analytics: Digitization, detecting novel pollutants and more